STANDARD BIOTOOLS INC (LAB) Stock Price, Forecast & Analysis
NASDAQ:LAB • US34385P1084
LAB Key Statistics, Chart & Performance
The current stock price of LAB is 1.12 USD. In the past month the price decreased by -29.11%. In the past year, price decreased by -20.57%.
LAB Technical Analysis
LAB Fundamental Analysis
ChartMill assigns a fundamental rating of 2 / 10 to LAB. While LAB seems to be doing ok healthwise, there are quite some concerns on its profitability.
LAB Financial Highlights
Over the last trailing twelve months LAB reported a non-GAAP Earnings per Share(EPS) of -0.34. The EPS increased by 52.11% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -23.77% | ||
| ROE | -32.09% | ||
| Debt/Equity | 0 |
LAB Forecast & Estimates
7 analysts have analysed LAB and the average price target is 1.58 USD. This implies a price increase of 41.16% is expected in the next year compared to the current price of 1.12.
For the next year, analysts expect an EPS growth of 52.25% and a revenue growth -53.07% for LAB
LAB Ownership
LAB Competitors/Peers
| Symbol | Company Name | Technical Rating | Fundamental Rating | FPE | Market Cap |
|---|---|---|---|---|---|
| TMO | THERMO FISHER SCIENTIFIC INC | 20.34 | 189.666B | ||
| DHR | DANAHER CORP | 25.03 | 150.273B | ||
| BRKRP | BRUKER CORP - BRKR 6 3/8 09/01/28 | 133.24 | 44.271B | ||
| A | AGILENT TECHNOLOGIES INC | 20.78 | 35.584B | ||
| IQV | IQVIA HOLDINGS INC | 12.76 | 28.313B | ||
| MTD | METTLER-TOLEDO INTERNATIONAL | 29.44 | 27.668B | ||
| WAT | WATERS CORP | 22.35 | 19.25B | ||
| WST | WEST PHARMACEUTICAL SERVICES | 31.91 | 18.02B | ||
| ILMN | ILLUMINA INC | 22.56 | 17.849B | ||
| MEDP | MEDPACE HOLDINGS INC | 25.46 | 12.058B |
Related stock screener links
View all stocks in the Life Sciences Tools & Services Industry | View all stocks in the Health Care Sector | View all stocks on the Nasdaq Exchange | Find stocks with similar TA and Setup ratings on the USA exchanges | Find stocks with similar Fundamental rating on the USA exchanges | Find the competitors with the best technical ratings on the USA exchanges | Find the competitors with the best fundamentals on the USA exchanges | Find the competitors with the best valuation on the USA exchanges | Find the competitors with the best dividend on the USA exchanges | Find the competitors with the best analyst ratings on the USA exchanges
About LAB
Company Profile
Standard BioTools Inc. engages in the provision of biotechnology tools and services for clinical research. The company is headquartered in Boston, Massachusetts and currently employs 818 full-time employees. The company went IPO on 2011-02-10. The firm's segments include Proteomics and Genomics. The Proteomics segment includes instruments, consumables, software, and services based upon technologies used in the identification of proteins. The Genomics segment includes instruments, consumables, software, and services based upon technologies used in the identification of genes (DNA, RNA) and their functions. The firm works with academic, government, pharmaceutical, biotechnology, plant and animal research, and clinical laboratories worldwide, focusing on the most pressing needs in translational and clinical research, including oncology, immunology, and immunotherapy. The company offers a diverse range of instrumentation, consumables, and services that generate data across early discovery, translational and clinical research.
Company Info
STANDARD BIOTOOLS INC
50 MILK STREET, 10TH FLOOR
Boston MASSACHUSETTS US
Employees: 818
Phone: 16502666000
STANDARD BIOTOOLS INC / LAB FAQ
What does STANDARD BIOTOOLS INC do?
Standard BioTools Inc. engages in the provision of biotechnology tools and services for clinical research. The company is headquartered in Boston, Massachusetts and currently employs 818 full-time employees. The company went IPO on 2011-02-10. The firm's segments include Proteomics and Genomics. The Proteomics segment includes instruments, consumables, software, and services based upon technologies used in the identification of proteins. The Genomics segment includes instruments, consumables, software, and services based upon technologies used in the identification of genes (DNA, RNA) and their functions. The firm works with academic, government, pharmaceutical, biotechnology, plant and animal research, and clinical laboratories worldwide, focusing on the most pressing needs in translational and clinical research, including oncology, immunology, and immunotherapy. The company offers a diverse range of instrumentation, consumables, and services that generate data across early discovery, translational and clinical research.
Can you provide the latest stock price for STANDARD BIOTOOLS INC?
The current stock price of LAB is 1.12 USD. The price increased by 0.9% in the last trading session.
What is the dividend status of STANDARD BIOTOOLS INC?
LAB does not pay a dividend.
How is the ChartMill rating for STANDARD BIOTOOLS INC?
LAB has a ChartMill Technical rating of 0 out of 10 and a ChartMill Fundamental rating of 2 out of 10.
What is STANDARD BIOTOOLS INC worth?
STANDARD BIOTOOLS INC (LAB) has a market capitalization of 430.72M USD. This makes LAB a Small Cap stock.
Can you provide the ownership details for LAB stock?
You can find the ownership structure of STANDARD BIOTOOLS INC (LAB) on the Ownership tab.